Fabtech Technologies
add_icon

Fabtech Technologies

156.50
-0.01
(-0.01%)
Market Cap
695.65 Cr
PE Ratio
22.15
Volume
46,224.00
Day High - Low
157.90 - 155.81
52W High-Low
262.80 - 132.70
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
695.65 Cr
EPS
14.34
PE Ratio
22.15
PB Ratio
1.63
Book Value
95.65
EBITDA
47.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
26.83
Debt to Equity
0.32
Forecast For
Actual

Company News

View All News
Caret
neutral
Fabtech Technologies Limited submitted its quarterly certificate under SEBI regulations for Q4FY26, confirming all shares remain in demat form with no rematerialisation requests received during the quarter.
positive
Fabtech Technologies Limited announced consolidated order book exceeding ₹900 crore as of March 31, 2026, while securing strategic projects in animal health, vaccines, and pharmaceutical sectors across Saudi Arabia and Africa.
neutral
Fabtech Technologies Limited announces appointment of Ms. Rupal Dhiren Haria as Additional Non-Executive Independent Director effective April 03, 2026, replacing Ms. Aparna Sharma whose tenure completes.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,473.20
#1 14,932.28
43.18
#1 1,759.00
22.62
#1 339
-16.90
60.73
211.82
1,127.02
56.61
408.40
32.64
30
-5.66
62.13
193.92
1,065.83
47.25
242.40
24.12
25
-58.33
55.31
558.95
989.04
49.25
186.60
40.62
20
-
50.53
156.50
#5 695.65
#1 22.15
#3 335.90
#2 45.66
#2 47
#7 -127.80
55.82
381.95
662.18
48.84
251.30
45.01
17
-67.50
46.53
445.00
534.12
26.69
67.10
13.15
18
4.44
60.77
227.75
433.64
27.58
136.30
#1 107.77
16
-
50.42
295.00
384.59
48.70
111.80
-
8
-
56.61
270.00
257.63
23.34
122.10
19.24
1
#1 232.14
58.87
Growth Rate
Revenue Growth
45.66 %
Net Income Growth
70.96 %
Cash Flow Change
-159.80 %
ROE
29.99 %
ROCE
10.88 %
EBITDA Margin (Avg.)
-15.99 %

Quarterly Financial Results

Quarterly Financials
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
49
61
106
138
71
125
70
Expenses
37
54
81
117
74
91
74
EBITDA
12
7
25
22
-4
34
-5
Operating Profit %
-28 %
8 %
22 %
14 %
-9 %
25 %
-18 %
Depreciation
1
1
1
1
1
1
1
Interest
0
0
0
1
1
1
1
Profit Before Tax
11
6
24
20
-6
31
-7
Tax
5
1
3
5
-0
3
-1
Net Profit
6
5
21
15
-6
28
-6
EPS in ₹
1.79
1.58
6.32
4.66
-1.89
8.68
-1.56

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
124
126
172
214
269
427
Fixed Assets
2
2
5
4
22
94
Current Assets
110
114
147
181
241
314
Capital Work in Progress
0
0
0
0
0
0
Investments
7
2
17
20
21
15
Other Assets
114
122
150
190
226
318
Total Equity & Liabilities
124
126
172
214
269
427
Current Liabilities
83
77
101
122
135
226
Non Current Liabilities
2
2
4
3
3
28
Total Equity
38
46
67
89
132
173
Reserve & Surplus
38
46
65
86
129
141
Share Capital
0
0
3
3
3
32

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
19
-20
Investing Activities
-30
-20
Operating Activities
60
-36
Financing Activities
-12
36

Share Holding

% Holding
Sept 2024
Sept 2025
Oct 2025
Dec 2025
Mar 2026
Promoter
94.61 %
68.94 %
68.94 %
68.94 %
68.94 %
FIIs
0.00 %
1.91 %
1.91 %
0.03 %
0.08 %
DIIs
0.00 %
11.63 %
11.63 %
1.99 %
2.15 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
16.09 %
16.09 %
22.25 %
21.71 %
Others
5.39 %
1.43 %
1.43 %
6.79 %
7.12 %
No of Share Holders
31
31
34
31,755
28,620

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
27 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2025 182.95 207.55
02 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
02 Feb 2026 160.55 163.50

Announcements

Board Meeting Intimation for Audited Financial Results And Dividend For Period Ended March 31 2026.3 hrs ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Announcement On Order Booking And Business UpdatesApr 04, 2026
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 27, 2026
Closure of Trading WindowMar 26, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held Today I.E. March 24 2026.Mar 24, 2026
Outcome Of Analysts/ Investors Meetings Held On March 10 2026Mar 11, 2026
Reply To The Clarification Sought By National Stock Exchange Of India Limited On Movement In Price Of The Shares Across Exchanges Of Shares Of The Company.Mar 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 26, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 14, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 10, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 04, 2026
Statement Of Nil Deviation Or Variation As Per Regulation 32 Of SEBI (LODR) Regulations 2015 For The Quarter Ended December 31 2025Feb 02, 2026
Unaudited Financial Results Of Quarter And Nine-Month Ended December 31 2025Feb 02, 2026
Board Meeting Outcome for Intimation Of Outcome Of Board Meeting.Feb 02, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Board Meeting Intimation for Intimation Of The Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Closure of Trading WindowDec 29, 2025
Outcome Of Analysts / Investors Meeting Held On December 26 2025Dec 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 18, 2025
Outcome Of Analysts / Investors Meeting Held On December 10 2025Dec 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 18, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 06, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderNov 04, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended September 30 2025Nov 04, 2025
Unaudited Standalone And Consolidated Financials Results Of The Company For The Quarter Ended June 30 2025Nov 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 28, 2025
Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30 2025Oct 27, 2025
Unaudited Standalone And Consolidated Financials Results Of The Company For The Quarter Ended June 30 2025Oct 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting- Disclosure Under Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 27, 2025
Board Meeting Outcome for Outcome Of Board Meeting- Disclosure Under Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 27, 2025
Board Meeting Intimation for Intimation Regarding Postponement And Rescheduling Of Board MeetingOct 23, 2025
Board Meeting Intimation for Intimation Of The Board Meeting Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Oct 16, 2025
Intimation Regarding Change Of Corporate Identifcation Number ("CIN") Of Fabtech Technologies LimitedOct 15, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.01%
0
0.00%
0.01%

Technical Indicators

RSI(14)
Neutral
55.83
ATR(14)
Less Volatile
8.44
STOCH(9,6)
Neutral
76.35
STOCH RSI(14)
Overbought
92.97
MACD(12,26)
Bullish
1.66
ADX(14)
Strong Trend
27.86
UO(9)
Bearish
48.73
ROC(12)
Uptrend And Accelerating
9.94
WillR(14)
Neutral
-21.52